PBA
GBT
Paradigm Biocapital Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,175,879
| Closed | -$80.1M | – | 31 |
|
|
2022
Q3 | $80.1M | Sell |
1,175,879
-269,687
| -19% | -$18.4M | 10.68% | 1 |
|
|
2022
Q2 | $46.2M | Buy |
1,445,566
+478,739
| +50% | +$15.3M | 9.21% | 2 |
|
|
2022
Q1 | $33.5M | Buy |
966,827
+186,347
| +24% | +$6.46M | 8.86% | 2 |
|
|
2021
Q4 | $22.8M | Buy |
+780,480
| New | +$22.8M | 6.52% | 6 |
|